Steven A. Wilcox

Partner

Wilcox-Steven-A-300
  • JD, cum laude, Boston College Law School, 1980; Member, Boston College Law Review
  • BA, summa cum laude, Boston College, 1977; Order of the Cross and Crown

Qualifications

  • Massachusetts, 1981
  • England and Wales, Solicitor, 2011
  • American Bar Association
  • Boston Bar Association
  • Massachusetts Bar Association
  • Massachusetts Biotechnology Council,  MassMEDIC, AdvaMed and BIO
  • Guest lectures on life sciences startup company dynamics at MIT and Harvard Medical School
  • Member, Board of Directors of Greater Boston Legal Services, a legal aid charitable organization
  • The Best Lawyers in America (2009-2018)
  • Legal 500 (2015-2017)
  • LMG Life Sciences: “Life Science Star” (2012-2013, 2016)
  • Chambers USA: America's Leading Lawyers for Business (2007-2013, 2015)
  • Martindale Hubble’s Peer Review, Preeminent Lawyer (2012)
  • PLC Which Lawyer (2010-2011)

Steven A. Wilcox

Partner

Steve Wilcox focuses his practice on mergers and acquisitions, corporate financing transactions (including public offerings and venture capital investments) and licensing and collaborations. Most of his clients are engaged in the biotech, medical device and pharmaceutical industries. In addition to transactional work, he regularly counsels companies on a range of federal securities and corporate governance matters.

Steve is a founder and former chair of the firm’s life sciences practice group.

Experience

Steve has been counsel to some of the world’s leading companies including Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, Johnson & Johnson, Medtronic, Millennium, Pfizer, Schering Plough, Smith & Nephew and Takeda Pharmaceuticals. Steve has also represented medical research institutions such as Cleveland Clinic, The Massachusetts General Hospital and Rockefeller University in connection with the spin-off or commercialization of their promising technologies. Steve has represented a number of entrepreneurs and venture capitalists in the life sciences industry, and the companies they have created, including AgeneBio, Alzheon, Blossom Innovations, Eléme Medical, InfoBionic, Normoxys, Percardia, pHLIP, Inc., Point Therapeutics, Salient Surgical, Vapotherm and Verax Biomedical.